Enhancement of mitochondrial calcium uptake is cardioprotective against maladaptive hypertrophy by retrograde signaling uptuning Akt
成果类型:
Article
署名作者:
Zaglia, Tania; Campo, Antonio; Moro, Nicola; Di Mauro, Vittoria; Borile, Giulia; Menabo, Roberta; Antonucci, Salvatore; Poli, Laura; Campesan, Marika; Carullo, Pierluigi; Martinazzi, Sara; Luciani, Giovanni B.; Hammer, Karin; Pesce, Paola; Bariani, Riccardo; Faggian, Giuseppe; Maier, Lars; Ventura, Laura; De Stefani, Diego; Mammucari, Cristina; Rizzuto, Rosario; Catalucci, Daniele; Di Lisa, Fabio; Mongillo, Marco
署名单位:
University of Padua; Veneto Institute Molecular Medicine; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Verona; University of Regensburg; University of Padua; University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR)
刊物名称:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
ISSN/ISSBN:
0027-9459
DOI:
10.1073/pnas.2402639122
发表日期:
2025-03-18
关键词:
induced heart-failure
cardiac-hypertrophy
mice lacking
in-vivo
overload
mcu
TRANSITION
stress
overexpression
cardiomyocytes
摘要:
Regulation of mitochondrial Ca2+ uptake is critical in cardiac adaptation to chronic stressors. Abnormalities in Ca2+ handling, including mitochondrial uptake mechanisms, have been implicated in pathological heart hypertrophy. Enhancing mitochondrial Ca2+uniporter (MCU) expression has been suggested to interfere with maladaptive development of heart failure. Here, we addressed whether MCU modulation affects the cardiac response to pressure overload. MCU content was quantified in human and murine hearts at different phases of myocardial hypertrophy. Cardiac function/structure were analyzed after Transverse Aortic Constriction (TAC) in mice undergone viral-assisted overexpression or downregulation of MCU. In vitro and ex vivo assays determined the effect of MCU modulation on mitochondrial Ca2+ uptake, cellular phenotype and hypertrophic signaling. In human and murine hearts MCU levels increased in the adaptive phase of myocardial hypertrophy and declined in the failing stage. Consistently, modulation of MCU had a cell-autonomous effect in cardiomyocyte/heart adaptation to chronic overload. Indeed, upon TAC MCU-downregulation accelerated development of contractile dysfunction, interstitial fibrosis and heart failure. Conversely, MCU-overexpression prolonged the adaptive phase of hypertrophic response, as, in advanced stages upon TAC, hearts showed preserved contractility, absence of fibrosis and intact vascularization. In vitro and ex vivo analyses indicated that enhancement in mitochondrial Ca2+ uptake in cardiomyocytes entails mitochondrion-to-cytoplasm signals leading to ROS-mediated activation of Akt, which may explain the protective effects towards heart response to TAC. Enhanced mitochondrial Ca2+ uptake affects the compensatory response to pressure overload via retrograde mitochondrial-Ca2+/ROS/Akt signaling, thus uncovering a potentially targetable mechanism against maladaptive myocardial hypertrophy.